Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
Top Cited Papers
Open Access
- 23 February 2008
- journal article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 51 (4), 546-553
- https://doi.org/10.1007/s00125-008-0942-y
Abstract
Mutations in the GCK and HNF1A genes are the most common cause of the monogenic forms of diabetes known as ‘maturity-onset diabetes of the young’. GCK encodes the glucokinase enzyme, which acts as the pancreatic glucose sensor, and mutations result in stable, mild fasting hyperglycaemia. A progressive insulin secretory defect is seen in patients with mutations in the HNF1A and HNF4A genes encoding the transcription factors hepatocyte nuclear factor-1 alpha and -4 alpha. A molecular genetic diagnosis often changes management, since patients with GCK mutations rarely require pharmacological treatment and HNF1A/4A mutation carriers are sensitive to sulfonylureas. These monogenic forms of diabetes are often misdiagnosed as type 1 or 2 diabetes. Best practice guidelines for genetic testing were developed to guide testing and reporting of results. A workshop was held to discuss clinical criteria for testing and the interpretation of molecular genetic test results. The participants included 22 clinicians and scientists from 13 countries. Draft best practice guidelines were formulated and edited using an online tool (http://www.coventi.com). An agreed set of clinical criteria were defined for the testing of babies, children and adults for GCK, HNF1A and HNF4A mutations. Reporting scenarios were discussed and consensus statements produced. Best practice guidelines have been established for monogenic forms of diabetes caused by mutations in the GCK, HNF1A and HNF4A genes. The guidelines include both diagnostic and predictive genetic tests and interpretation of the results.This publication has 47 references indexed in Scilit:
- Macrosomia and Hyperinsulinaemic Hypoglycaemia in Patients with Heterozygous Mutations in the HNF4A GenePLoS Medicine, 2007
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2007
- A Hepatocyte Nuclear Factor-4α Gene (HNF4A) P2 Promoter Haplotype Linked With Late-Onset DiabetesDiabetes, 2006
- Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunctionNature Genetics, 2005
- β-Cell Dysfunction, Insulin Sensitivity, and Glycosuria Precede Diabetes in Hepatocyte Nuclear Factor-1α Mutation CarriersDiabetes Care, 2005
- No Deterioration in Glycemic Control in HNF-1α Maturity-Onset Diabetes of the Young Following Transfer From Long-Term Insulin to SulphonylureasDiabetes Care, 2003
- Detecting Polymorphisms and Mutations in Candidate GenesAmerican Journal of Human Genetics, 2002
- Cloning and sequencing of cDNAs encoding the human hepatocyte nuclear factor 4 indicate the presence of two isoforms in human liverGene, 1994
- Deletion of the donor splice site of intron 4 in the glucokinase gene causes maturity-onset diabetes of the young.JCI Insight, 1993
- Administration of Sulfonylureas Can Increase Glucose-Induced Insulin Secretion for Decades in Patients With Maturity-Onset Diabetes of the YoungDiabetes Care, 1993